Development of a Protein Standard Absolute Quantification (PSAQ™) assay for the quantification of Staphylococcus aureus enterotoxin A in serum

Journal of Proteomics

Volumn 75, Issue 10, 2012, Pages 3041-3049

  Adrait, Annie ^a,b,c   Lebert, Dorothée ^a,b,c,d   Trauchessec, Mathieu ^a,b,c   Dupuis, Alain ^a,b,c   Louwagie, Mathilde ^a,b,c   Masselon, Christophe ^a,b,c   Jaquinod, Michel ^a,b,c   Chevalier, Benoît ^e   Vandenesch, François ^b,f   Garin, Jérôme ^a,b,c   Bruley, Christophe ^a,b,c   Brun, Virginie ^a,b,c,d  

^a CEA GRENOBLE   (France)

^b INSERM   (France)

^c UNIV GRENOBLE ALPES   (France)

^d Promise Advanced Proteomics   (France)

^e HIA Desgenettes   (France)

^f UNIVERSITÉ LYON 1   (France)

Author keywords

Absolute quantification; Enterotoxin; Mass spectrometry; PSAQ; Sepsis; SRM

Indexed keywords

STAPHYLOCOCCUS AUREUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN A; UNCLASSIFIED DRUG;

ACCURACY; ANTIBODY AFFINITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ISOTOPE LABELING; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MONITORING; PRIORITY JOURNAL; PROTEIN STANDARD ABSOLUTE QUANTIFICATION ASSAY; PROTEOMICS; QUANTITATIVE ANALYSIS; SELECTED REACTION MONITORING; SENSITIVITY AND SPECIFICITY; TITRIMETRY; TOXIN ANALYSIS;

AMINO ACID SEQUENCE; BLOOD CHEMICAL ANALYSIS; ENTEROTOXINS; HUMANS; IMMUNOCHEMISTRY; MASS SPECTROMETRY; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; PROTEINS; PROTEOMICS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 84861344085     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.11.031     Document Type: Article

References (33)

1. Fraser J.D., Proft T. The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008, 225:226-243.
2. Lina G., Gillet Y., Vandenesch F., Jones M.E., Floret D., Etienne J. Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis 1997, 25:1369-1373.
3. Ferry T., Thomas D., Genestier A.L., Bes M., Lina G., Vandenesch F., et al. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis 2005, 41:771-777.
4. Dauwalder O., Thomas D., Ferry T., Debard A.L., Badiou C., Vandenesch F., et al. Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock. J Leukoc Biol 2006, 80:753-758.
5. Dauwalder O., Pachot A., Cazalis M.A., Paye M., Faudot C., Badiou C., et al. Early kinetics of the transcriptional response of human leukocytes to staphylococcal superantigenic enterotoxins A and G. Microb Pathog 2009, 47:171-176.
6. Thomas D., Chou S., Dauwalder O., Lina G. Diversity in Staphylococcus aureus enterotoxins. Chem Immunol Allergy 2007, 93:24-41.
7. Ferry T., Thomas D., Perpoint T., Lina G., Monneret G., Mohammedi I., et al. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock. Clin Microbiol Infect 2008, 14:546-554.
8. Ackermann B.L., Berna M.J. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers. Expert Rev Proteomics 2007, 4:175-186.
9. Lange V., Picotti P., Domon B., Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 2008, 4:222.
10. Ho E.N., Wan T.S., Wong A.S., Lam K.K., Stewart B.D. Doping control analysis of insulin and its analogues in equine plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2008, 1201:183-190.
11. Guan F., Uboh C.E., Soma L.R., Birks E., Chen J., You Y., et al. Differentiation and identification of recombinant human erythropoietin and darbepoetin Alfa in equine plasma by LC-MS/MS for doping control. Anal Chem 2008, 80:3811-3817.
12. Dubois M., Becher F., Herbet A., Ezan E. Immuno-mass spectrometry assay of EPI-HNE4, a recombinant protein inhibitor of human elastase. Rapid Commun Mass Spectrom 2007, 21:352-358.
13. Dubois M., Fenaille F., Clement G., Lechmann M., Tabet J.C., Ezan E., et al. Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum. Anal Chem 2008, 80:1737-1745.
14. Xu Y., Mehl J.T., Bakhtiar R., Woolf E.J. Immunoaffinity purification using anti-PEG antibody followed by two-dimensional liquid chromatography/tandem mass spectrometry for the quantification of a PEGylated therapeutic peptide in human plasma. Anal Chem 2010, 82:6877-6886.
15. Berna M., Ott L., Engle S., Watson D., Solter P., Ackermann B. Quantification of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: a biomarker of drug-induced cardiac hypertrophy. Anal Chem 2008, 80:561-566.
16. Bredehoft M., Schanzer W., Thevis M. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom 2008, 22:477-485.
17. Hoofnagle A.N., Becker J.O., Wener M.H., Heinecke J.W. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 2008, 54:1796-1804.
18. Keshishian H., Addona T., Burgess M., Kuhn E., Carr S.A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2007, 6:2212-2229.
19. Nicol G.R., Han M., Kim J., Birse C.E., Brand E., Nguyen A., et al. Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients. Mol Cell Proteomics 2008, 7:1974-1982.
20. Brun V., Dupuis A., Adrait A., Marcellin M., Thomas D., Court M., et al. Isotope-labeled protein standards: toward absolute quantitative proteomics. Mol Cell Proteomics 2007, 6:2139-2149.
21. Arsene C.G., Ohlendorf R., Burkitt W., Pritchard C., Henrion A., O'Connor G., et al. Protein quantification by isotope dilution mass spectrometry of proteolytic fragments: cleavage rate and accuracy. Anal Chem 2008, 80:4154-4160.
22. Brun V., Masselon C., Garin J., Dupuis A. Isotope dilution strategies for absolute quantitative proteomics. J Proteomics 2009, 72:740-749.
23. Lesur A., Varesio E., Hopfgartner G. Accelerated tryptic digestion for the analysis of biopharmaceutical monoclonal antibodies in plasma by liquid chromatography with tandem mass spectrometric detection. J Chromatogr A 2010, 1217:57-64.
24. Thomas D., Dauwalder O., Brun V., Badiou C., Ferry T., Etienne J., et al. Staphylococcus aureus superantigens elicit redundant and extensive human V{beta} patterns. Infect Immun 2009, 77:2043-2050.
25. Jaquinod M., Villiers F., Kieffer-Jaquinod S., Hugouvieux V., Bruley C., Garin J., et al. A proteomics dissection of Arabidopsis thaliana vacuoles isolated from cell culture. Mol Cell Proteomics 2007, 6:394-412.
26. Sargent M., Harrigton C., Harte R. Guidelines for achieving high accuracy in isotope dilution mass spectrometry (IDMS) 2002.
27. Le Loir Y., Baron F., Gautier M. Staphylococcus aureus and food poisoning. Genet Mol Res 2003, 2:63-76.
28. Keshishian H., Addona T., Burgess M., Mani D.R., Shi X., Kuhn E., et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2009, 8:2339-2349.
29. Dupuis A., Hennekinne J.A., Garin J., Brun V. Protein Standard Absolute Quantification (PSAQ) for improved investigation of staphylococcal food poisoning outbreaks. Proteomics 2008, 8:4633-4636.
30. Sherman J., McKay M.J., Ashman K., Molloy M.P. How specific is my SRM? The issue of precursor and product ion redundancy. Proteomics 2009, 9:1120-1123.
31. Hanke S., Besir H., Oesterhelt D., Mann M. Absolute SILAC for accurate quantitation of proteins in complex mixtures down to the attomole level. J Proteome Res 2008, 7:1118-1130.
32. Stahl-Zeng J., Lange V., Ossola R., Eckhardt K., Krek W., Aebersold R., et al. High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol Cell Proteomics 2007, 6:1809-1817.
33. Brownridge P., Beynon R.J. The importance of the digest: proteolysis and absolute quantification in proteomics. Methods 2011, 54:351-360.